Status:
COMPLETED
Chest Pain Pilot Study
Lead Sponsor:
AstraZeneca
Conditions:
Chest Pain
Gastroesophageal Reflux
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the efficacy of Nexium® with placebo in relief of acid related pain or discomfort in the chest.
Eligibility Criteria
Inclusion
- Pain or discomfort in the chest without any identifiable cause and severe enough for the patient to seek primary medical or similar care.
- History of pain or discomfort in the chest for at least the last two weeks prior to enrollment.
Exclusion
- Signs, symptoms or relevant investigations suggestion present symptomatic coronary heart disease.
- Patients whose pain or discomfort in the chest warrants urgent cardiac investigation.
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
End Date :
July 1 2005
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00251901
Start Date
May 1 2004
End Date
July 1 2005
Last Update
January 24 2011
Active Locations (80)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Calgary, Alberta, Canada
2
Research Site
Edmonton, Alberta, Canada
3
Research Site
Penticton, British Columbia, Canada
4
Research Site
Winkler, Manitoba, Canada